Table 3.

Subcutaneous abatacept security profile.

Adverse events	n (%)
Infections
Common cold	102 (64.1)
Urinary tract infection	18 (11.3)
Soft tissue infection	15 (9.4)
Bronchitis	14 (8.8)
Pharyngitis	13 (8.2)
Gastroenteritis	11 (6.9)
Herpes zoster	9 (5.6)
Systemic injection reactions
Constitutional symptoms	65 (40.9)
Gastrointestinal symptoms	40 (25.6)
Sicca symptoms	35 (22)
Respiratory symptoms	19 (11.9)
Others
Headache	64 (40.3)
Arthralgia	28 (17.6)
Dizziness	23 (14.5)
Skin rash	18 (11.3)
Local injection-site reactions
Pain	20 (12.6)
Hematoma	17 (10.7)
Edema	8 (5)
Erythema	7 (4.4)
Pruritus	7 (4.4)
Papule	5 (3.1)
Burning	5 (3.1)
Irritation	3 (1.9)